Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1

Eye

Volumn 25, Issue 6, 2011, Pages 818-

  Gutmann, D H ^a   Listernick, R ^b   Ferner, R E ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; EXOPHTHALMOS; GLAUCOMA; GLIOMA; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; LETTER; MASS SCREENING; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE LESION; VISION TEST; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM;

EID: 79958744743     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.227     Document Type: Letter

References (5)

1. Simmons I, Gogi D. Screening children with NF1 for optic pathway glioma-Yes. Eye (Lond) 2010;24(9):1429-1431.
2. Pilling RF, Taylor RH. Screening children with NF1 for optic pathway glioma-No. Eye (Lond) 2010;24(9):1432-1434.
3. Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 2007;61(3):189-198. (Pubitemid 46557343)
4. Grill J, Laithier V, Rodriguez D, Raquin MA, Pierre-Kahn A, Kalifa C. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr 2000;159(9):692-696. (Pubitemid 30658557)
5. Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J. Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 2004;63(10):1944-1946. (Pubitemid 39532398)